Tixagevimab/Cilgavimab in SARS-CoV-2 Prophylaxis and Therapy: A Comprehensive Review of Clinical Experience
Effective treatments and vaccines against COVID-19 used in clinical practice have made a positive impact on controlling the spread of the pandemic, where they are available. Nevertheless, even if fully vaccinated, immunocompromised patients still remain at high risk of adverse outcomes. This has dri...
Guardat en:
| Autors principals: | , , , , , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
MDPI AG
2022-12-01
|
| Col·lecció: | Viruses |
| Matèries: | |
| Accés en línia: | https://www.mdpi.com/1999-4915/15/1/118 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|